SCHEMBL14075396

SCHEMBL14075396

COc1ccc(S(=O)(=O)Nc2ccc(Oc3ccc(NS(=O)(=O)c4ccc(OC)cc4)c(C(=O)O)c3)cc2C(=O)O)cc1

nearest known ligand 0.73

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.73
CYP1A2 P05177 1/20 0.73
KEAP1 Q14145 2/20 0.66
NFE2L2 Q16236 2/20 0.66
CYP2C19 P33261 1/20 0.59
ALDH1A1 P00352 3/20 0.58
KDM4E B2RXH2 2/20 0.58
RCE1 Q9Y256 1/20 0.58
POLB P06746 1/20 0.56
SQSTM1 Q13501 1/20 0.56
METAP2 P50579 3/20 0.56
FFAR4 Q5NUL3 1/20 0.56
MCL1 Q07820 1/20 0.55
BCL2A1 Q16548 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5955445 0.94 CYP2C9 (0.84) CYP2C9CYP1A2KEAP1NFE2L2CYP2C19
SCHEMBL14075311 0.91 ALDH1A1 (0.74) CYP2C9CYP1A2KEAP1NFE2L2CYP2C19
SCHEMBL3512984 0.89 CYP2C9 (0.90) CYP2C9CYP1A2KEAP1NFE2L2CYP2C19
SCHEMBL14075367 0.89 CYP2C9 (0.73) CYP2C9CYP1A2KEAP1NFE2L2CYP2C19
SCHEMBL14075371 0.89 CYP2C9 (0.63) CYP2C9CYP1A2KEAP1NFE2L2CYP2C19
SCHEMBL12200967 0.88 CYP2C9 (0.76) CYP2C9CYP1A2KEAP1NFE2L2CYP2C19
SCHEMBL7322109 0.88 METAP2 (0.73) CYP2C9CYP1A2KEAP1NFE2L2CYP2C19
SCHEMBL10249221 0.87 ACLY (0.67) KEAP1NFE2L2ALDH1A1METAP2
SCHEMBL14075392 0.87 CYP2C9 (0.70) CYP2C9CYP1A2KEAP1NFE2L2CYP2C19
SCHEMBL3514014 0.87 CYP2C9 (0.77) CYP2C9CYP1A2KEAP1NFE2L2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429677-B2 Small molecule entry inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-09-30 US disclosed
US-7429677-B2 Small molecule entry inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-09-30 US disclosed